The U.S. Food and Drug Administration (FDA) approved six new therapies in December 2025 for blood cancers, prostate cancer, ...

Rybrevant Faspro, the new subcutaneous version of amivantamab, was approved for patients with a specific form of lung cancer ...

Lung cancer patients receiving immunochemotherapy earlier in the day had a 52% lower risk of progression in a new medical ...

Radiation therapy is a treatment that uses high-energy rays, like X-rays, gamma rays or protons, to target and destroy cancer cells. It works by damaging the DNA of cancer cells, preventing them from ...

The EVEREST-2 study reported the first complete response to CAR-T cell therapy in a non-small cell lung cancer patient.

The field of cancer treatment saw a variety of advancements in 2025, from new dedicated centers to approved treatments to ...

Targeted therapies are cancer medications that work more selectively than standard chemotherapy medications. They do this by targeting specific molecules or genetic changes in cancer cells in order to ...

Thanks to recent therapy advances, the lung cancer mortality rate has declined and survival rates have improved. Many factors influence the likelihood of a lung cancer cure or long-term survival, ...

“Lung cancer, though common and serious, still has many misconceptions,” says Ian Bostock, MD, a thoracic surgeon at Miami Cancer Institute in Florida. “Clearing these myths helps patients and ...

Diarrhea is not a common direct symptom of lung cancer itself, but it can occur in advanced stages due to the cancer’s impact on the immune system. The primary reason lung cancer patients experience ...